Gandersen’s doctors say the “pause” of the J & J COVID-19 vaccine trial is not the cause of imminent concern | Local News

The next step is to determine if the disease has anything to do with receiving the vaccine. This requires investigating, examining epidemiological data, and examining research protocols before deciding whether it is safe to resume the trial.

“Things can be temporally related, but they don’t cause any effect,” Nike says, referring to confounding variables. “… Just because two things are related doesn’t mean that one caused the other.”

If the vaccine proves to be the cause of the study participants’ illness, whether the vaccine advances depends on the severity of their effects and their likelihood.

“If something is rarely associated with a vaccine, the benefits of the vaccine can outweigh the risks and do not necessarily rule out the vaccine,” says Naik. “It really depends on the severity of the reaction-this may just end up in labeling” just as prescription drugs involve a list of potential side effects experienced by a small number of users.

It is premature to consider the suspension a concern, and repeating such events is “not unexpected and not necessarily a significant recession in progress,” Nike said.

“We know we’re against the pandemic timeline, but ultimately, most importantly, scientists, vaccine companies, the FDA, and everyone who will receive the vaccine do it right. It’s important to understand. The benefits of vaccines with minimal risk and side effects. ” “So I don’t think this is a problem. In fact, I think this is proof that the scientific system of checking and balancing is working as expected.”